layoffs
-
Apellis Lays Off 25% of Staff and Turns Focus to Commercializing New Eye Drug
The Apellis Pharmaceuticals restructuring will save up to $300 million. It comes as the biotech continues its inquiry into the cause of a rare inflammatory complication reported in a small number of patients who received its geographic atrophy drug, Syfovre.
-
Consumer / Employer, Devices & Diagnostics, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Andrew Trister, Chief Scientific Officer at Verily
For the August episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Andrew Trister, who just became Verily’s chief scientific officer.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences
In this month’s episode, we dive into some recent executive appointments occurring in the healthcare world, as well as layoffs affecting the industry. We also hear from Leslie Orne, who recently became the new CEO of Trinity Life Sciences, which provides consulting services and technology solutions to life sciences firms looking to commercialize their product.
-
Amarin Restructures, Charting Course That Braces for Generic Competition
The restructuring of cardiovascular drugmaker Amarin means the layoff of about 30% of staff. Sales of Vascepa, the company’s only commercialized product, have suffered as generic versions gain traction in the market.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Danny Sanchez, CEO of EmpiRx Health
In this month’s episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Danny Sanchez, who recently became the new CEO of EmpiRx Health, a value-based pharmacy benefit manager.
-
Consumer / Employer, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Lara Khouri, COO of Children’s Hospital Los Angeles
In this month’s episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Lara Khouri, the new COO of Children’s Hospital Los Angeles, about her passion for pediatric healthcare.
-
With Halo Shutdown, Amazon Has Now Closed 3 of Its Healthcare Divisions Since 2021
Amazon recently announced that it is shuttering its Halo division, a line of wearable health and fitness devices. This marks the third time in about two years that the e-commerce giant has closed one its healthcare businesses — Amazon Care failed last year, and Haven failed in 2021.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Rob Fields, Beth Israel Lahey Health’s New Chief Clinical Officer
In this month’s episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Dr. Rob Fields, who recently switched from his role as chief population health officer at Mount Sinai to chief clinical officer at Beth Israel Lahey Health.
-
Consumer / Employer, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Tom Richards, Transcarent’s New EVP of Business Development
In this month’s episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Tom Richards, who recently became the new executive vice president of business development at Transcarent after spending more than 35 years at Cigna.
-
‘Challenging Market’ Leads MorphoSys to Cut Preclinical R&D, Turn Focus to Cancer
MorphoSys’s emphasis on its clinical-stage cancer programs puts the spotlight on a myelofibrosis drug candidate from its 2021 acquisition of Constellation Pharmaceuticals. That small molecule could compete against drug candidates from GSK and Merck.
-
Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures
While Talaris Therapeutics is ending two clinical tests of its cell therapy in kidney transplant patients, a third study in the autoimmune condition scleroderma is continuing. Meanwhile, the biotech’s restructuring plan is pursuing “strategic alternatives” that could include a merger or sale.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
